Therese Aubry-de Maraumont, L. M. Camacho-Cordero, Mónica Alva-Esqueda, A. Hernández-Garduño, J. A. Guzmán-Caniupan, Fernando Carlos-Rivera
{"title":"evolocumab在原发性高胆固醇血症和不受控制的混合血脂异常高危心血管疾病患者中的经济评价","authors":"Therese Aubry-de Maraumont, L. M. Camacho-Cordero, Mónica Alva-Esqueda, A. Hernández-Garduño, J. A. Guzmán-Caniupan, Fernando Carlos-Rivera","doi":"10.35366/105819","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":283429,"journal":{"name":"Cardiovascular and Metabolic Science","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluación económica de evolocumab en pacientes con enfermedad cardiovascular de alto riesgo con hipercolesterolemia primaria y dislipidemia mixta no controlados\",\"authors\":\"Therese Aubry-de Maraumont, L. M. Camacho-Cordero, Mónica Alva-Esqueda, A. Hernández-Garduño, J. A. Guzmán-Caniupan, Fernando Carlos-Rivera\",\"doi\":\"10.35366/105819\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":283429,\"journal\":{\"name\":\"Cardiovascular and Metabolic Science\",\"volume\":\"25 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular and Metabolic Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35366/105819\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular and Metabolic Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35366/105819","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluación económica de evolocumab en pacientes con enfermedad cardiovascular de alto riesgo con hipercolesterolemia primaria y dislipidemia mixta no controlados